However, Src inhibition did not affect the invasive capacities of both shCTRL and shLRP-1 cells (Fig. 4H), thereby excluding Src kinase contribution to LRP-1-mediated ERK activation during carcinoma cell invasion. The gene discussed is LRP1; the disease is carcinoma.